Forward Pharma A/S (FWP)

NASDAQ: FWP · IEX Real-Time Price · USD
3.25
0.00 (0.00%)
At close: Sep 22, 2022 12:00 AM
3.26
+0.01 (0.31%)
After-hours: Sep 22, 2022 4:00 PM EDT
0.00%
Market Cap 23.05M
Revenue (ttm) n/a
Net Income (ttm) -1.89M
Shares Out 7.09M
EPS (ttm) -0.27
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 2,583
Open 3.26
Previous Close 3.25
Day's Range 3.25 - 3.34
52-Week Range 3.25 - 7.22
Beta 1.30
Analysts Sell
Price Target n/a
Earnings Date n/a

About FWP

Forward Pharma A/S does not have significant operations. Previously, it operated as a biopharmaceutical company that focused on developing FP187 proprietary formulation of dimethyl fumarate for the treatment of inflammatory and neurological indications. Forward Pharma A/S was incorporated in 2005 and is headquartered in Copenhagen, Denmark. [Read more...]

Industry Biotechnology
Founded 2005
CEO Claus Svendsen
Employees 4
Stock Exchange NASDAQ
Ticker Symbol FWP
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecast

No stock price forecast available yet.

Price Target
n/a
Analyst Consensus: Sell
Stock Forecasts

News

Forward Pharma Reports Financial and Operating Results for the Year Ended December 31, 2021

COPENHAGEN, Denmark, April 08, 2022 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ:FWP) (“we,” “Forward” or the “Company” and, together with its subsidiaries, the “Group”), today reported consolidated f...

5 months ago - GlobeNewsWire

Why is Forward Pharma Stock Plunging During Premarket Tuesday?

The stock price of Forward Pharma A/S (NASDAQ: FWP) fell by almost 20% during the premarket.  Investors are responding negatively to the Technical Board of Appeal (TBA) of the European Patent Office (EP...

1 year ago - Benzinga

Forward Pharma Announces the Decision of the Technical Board of Appeal of the European Patent Office in the EP2801355...

COPENHAGEN, Denmark, Sept. 06, 2021 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ:FWP) (“we,” “Forward” or the “Company”), today announced that the Technical Board of Appeal (the “TBA”) of the European...

1 year ago - GlobeNewsWire

Forward Pharma Reports Financial and Operational Results from the Year Ended December 31, 2020

COPENHAGEN, Denmark, April 14, 2021 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ:FWP) (“We,” “Forward” or the “Company” and, together with its subsidiaries, the “Group”), today reported consolidated f...

1 year ago - GlobeNewsWire

Forward Pharma Announces Rescheduling of the EP2801355 Appeal Hearing to September 6, 2021 due to COVID-19 Restrictions

COPENHAGEN, Denmark, Jan. 12, 2021 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ:FWP) (“we,” “Forward” or the “Company”), today announced that due to ongoing precautionary measures against the spread o...

1 year ago - GlobeNewsWire

A Trio of Stock Picks for the Short-Term Investor

There are investors who purchase shares of stocks that are trading below their liquidation value in the belief that they can make huge gains out of their investments after the market has reassessed the ...

Other symbols: APWC
2 years ago - GuruFocus

Forward Pharma A/S Announces Change in Ratio of American Depositary Shares to Ordinary Shares

COPENHAGEN, Denmark, Nov. 26, 2019 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ:FWP) (“Forward” or the “Company”) today announced that its Board of Directors has approved a change in the number of i...

2 years ago - GlobeNewsWire

Forward Pharma to Participate in the Fall Investor Summit in New York

COPENHAGEN, Denmark, Sept. 05, 2019 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ:FWP) (the “Company”) today announced that Chief Executive Officer, Dr. Claus Bo Svendsen, will participate in the Fal...

3 years ago - GlobeNewsWire